Literature DB >> 17379543

Effect of puerarin on bone formation.

R Wong1, B Rabie.   

Abstract

OBJECTIVE: Puerarin is one of the major phytoestrogens isolated from Pueraria lobata, a Chinese medicine known as Gegen. Our laboratory compared the amount of new bone produced by puerarin in collagen matrix (carrier) to that produced by the collagen matrix alone.
METHOD: Eighteen bone defects, 5mm by 10mm were created in the parietal bone of nine New Zealand White rabbits. In the experimental group, six defects were grafted with puerarin solution mixed with collagen matrix. In the control groups, six defects were grafted with collagen matrix alone (active control) and six were left empty (passive control). Animals were killed on day 14 and the defects were dissected and prepared for histological assessment. Serial sections were cut across each defect. No new bone was formed in the passive control group. Quantitative analysis of new bone formation was made on 100 sections (10 sections in each defect, in five defects randomly selected in each of the experimental group and active control group) using image analysis.
RESULTS: A total of 554% more new bone was present in defects grafted with puerarin in collagen matrix than those grafted with the collagen matrix alone.
CONCLUSION: Puerarin in collagen matrix has the effect of increasing new bone formation locally and can be used for bone grafting or for bone induction often required in surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379543     DOI: 10.1016/j.joca.2007.02.009

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  21 in total

Review 1.  The role of small molecules in musculoskeletal regeneration.

Authors:  Kevin W-H Lo; Keshia M Ashe; Ho Man Kan; Cato T Laurencin
Journal:  Regen Med       Date:  2012-07       Impact factor: 3.806

2.  Effect of bio-oss collagen and collagen matrix on bone formation.

Authors:  R W K Wong; A B M Rabie
Journal:  Open Biomed Eng J       Date:  2010-03-09

3.  Puerarin inhibits proliferation and induces apoptosis in human glioblastoma cell lines.

Authors:  Ji-An Yang; Ji-Qiang Li; Ling-Min Shao; Qian Yang; Bao-Hui Liu; Ting-Feng Wu; Peng Wu; Wei Yi; Qian-Xue Chen
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Phytoestrogens induce differential estrogen receptor beta-mediated responses in transfected MG-63 cells.

Authors:  Xiaolu Tang; Xiaoyan Zhu; Shujuan Liu; Richard C Nicholson; Xin Ni
Journal:  Endocrine       Date:  2008-10-21       Impact factor: 3.633

5.  Puerarin suppresses proliferation of endometriotic stromal cells partly via the MAPK signaling pathway induced by 17ß-estradiol-BSA.

Authors:  Wen Cheng; Lizao Chen; Shengsheng Yang; Jie Han; Dongxia Zhai; Jian Ni; Chaoqin Yu; Zailong Cai
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

6.  Puerarin attenuates glucocorticoid-induced apoptosis of hFOB1.19 cells through the JNK- and Akt-mediated mitochondrial apoptotic pathways.

Authors:  Dongdong Yu; Shuai Mu; Danyang Zhao; Guangbin Wang; Zhiguang Chen; Hongfei Ren; Qin Fu
Journal:  Int J Mol Med       Date:  2015-06-23       Impact factor: 4.101

7.  Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF-β Signaling Pathway Activation in Type 2 Diabetic Rats.

Authors:  Biyu Hou; Yuerong Zhao; Guifen Qiang; Xiuying Yang; Chunyang Xu; Xi Chen; Chenge Liu; Xiaobo Wang; Li Zhang; Guanhua Du
Journal:  Oxid Med Cell Longev       Date:  2018-07-02       Impact factor: 6.543

8.  Puerarin promotes osteogenesis and inhibits adipogenesis in vitro.

Authors:  Nan Wang; Xinluan Wang; Wenxiang Cheng; Huijuan Cao; Peng Zhang; Ling Qin
Journal:  Chin Med       Date:  2013-08-21       Impact factor: 5.455

9.  Effect of quercetin on preosteoblasts and bone defects.

Authors:  R W K Wong; A B M Rabie
Journal:  Open Orthop J       Date:  2008-03-10

10.  Puerarin promotes the proliferation and differentiation of MC3T3-E1 cells via microRNA-106b by targeting receptor activator of nuclear factor-κB ligand.

Authors:  Zimei Shan; Na Cheng; Rong Huang; Bin Zhao; Yali Zhou
Journal:  Exp Ther Med       Date:  2017-10-31       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.